COMBINATION PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD

Provided is a novel cancer treatment means in which a reversible BTK inhibitor and an immunity checkpoint inhibitor are combined. For example, provided is a pharmaceutical composition for treating cancer wherein BTK inhibitor (I-A) and an anti PD-1 antibody are combined. L'invention concerne un...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KASHIMOTO, Shigeki, SAWA, Masaaki
Format: Patent
Sprache:eng ; fre ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KASHIMOTO, Shigeki
SAWA, Masaaki
description Provided is a novel cancer treatment means in which a reversible BTK inhibitor and an immunity checkpoint inhibitor are combined. For example, provided is a pharmaceutical composition for treating cancer wherein BTK inhibitor (I-A) and an anti PD-1 antibody are combined. L'invention concerne un nouveau moyen de traitement du cancer dans lequel un inhibiteur de BTK réversible et un inhibiteur de point de contrôle de l'immunité sont combinés. Par exemple, l'invention concerne une composition pharmaceutique pour le traitement du cancer, dans laquelle un inhibiteur de BTK (I-A) et un anticorps anti-PD-1 sont combinés. 新しいがん治療手段として、可逆的BTK阻害剤と免疫チェックポイント阻害剤とを組み合わせた治療手段、例えば、下記BTK阻害剤(I-A): および抗PD-1抗体との組み合わせによる、がん治療のための医薬組成物が提供される。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022102715A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022102715A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022102715A13</originalsourceid><addsrcrecordid>eNrjZLB29vd18vRzDPH091MI8HAM8nV0dg0N8XR29FEASgX4B3uCpRz9XBRCglwdQ3xd_UIUfF1DPPxdeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRkaGBkbmhqaOhMXGqAKaZKnA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD</title><source>esp@cenet</source><creator>KASHIMOTO, Shigeki ; SAWA, Masaaki</creator><creatorcontrib>KASHIMOTO, Shigeki ; SAWA, Masaaki</creatorcontrib><description>Provided is a novel cancer treatment means in which a reversible BTK inhibitor and an immunity checkpoint inhibitor are combined. For example, provided is a pharmaceutical composition for treating cancer wherein BTK inhibitor (I-A) and an anti PD-1 antibody are combined. L'invention concerne un nouveau moyen de traitement du cancer dans lequel un inhibiteur de BTK réversible et un inhibiteur de point de contrôle de l'immunité sont combinés. Par exemple, l'invention concerne une composition pharmaceutique pour le traitement du cancer, dans laquelle un inhibiteur de BTK (I-A) et un anticorps anti-PD-1 sont combinés. 新しいがん治療手段として、可逆的BTK阻害剤と免疫チェックポイント阻害剤とを組み合わせた治療手段、例えば、下記BTK阻害剤(I-A): および抗PD-1抗体との組み合わせによる、がん治療のための医薬組成物が提供される。</description><language>eng ; fre ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220519&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022102715A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220519&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022102715A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KASHIMOTO, Shigeki</creatorcontrib><creatorcontrib>SAWA, Masaaki</creatorcontrib><title>COMBINATION PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD</title><description>Provided is a novel cancer treatment means in which a reversible BTK inhibitor and an immunity checkpoint inhibitor are combined. For example, provided is a pharmaceutical composition for treating cancer wherein BTK inhibitor (I-A) and an anti PD-1 antibody are combined. L'invention concerne un nouveau moyen de traitement du cancer dans lequel un inhibiteur de BTK réversible et un inhibiteur de point de contrôle de l'immunité sont combinés. Par exemple, l'invention concerne une composition pharmaceutique pour le traitement du cancer, dans laquelle un inhibiteur de BTK (I-A) et un anticorps anti-PD-1 sont combinés. 新しいがん治療手段として、可逆的BTK阻害剤と免疫チェックポイント阻害剤とを組み合わせた治療手段、例えば、下記BTK阻害剤(I-A): および抗PD-1抗体との組み合わせによる、がん治療のための医薬組成物が提供される。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB29vd18vRzDPH091MI8HAM8nV0dg0N8XR29FEASgX4B3uCpRz9XBRCglwdQ3xd_UIUfF1DPPxdeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRkaGBkbmhqaOhMXGqAKaZKnA</recordid><startdate>20220519</startdate><enddate>20220519</enddate><creator>KASHIMOTO, Shigeki</creator><creator>SAWA, Masaaki</creator><scope>EVB</scope></search><sort><creationdate>20220519</creationdate><title>COMBINATION PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD</title><author>KASHIMOTO, Shigeki ; SAWA, Masaaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022102715A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; jpn</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KASHIMOTO, Shigeki</creatorcontrib><creatorcontrib>SAWA, Masaaki</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KASHIMOTO, Shigeki</au><au>SAWA, Masaaki</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD</title><date>2022-05-19</date><risdate>2022</risdate><abstract>Provided is a novel cancer treatment means in which a reversible BTK inhibitor and an immunity checkpoint inhibitor are combined. For example, provided is a pharmaceutical composition for treating cancer wherein BTK inhibitor (I-A) and an anti PD-1 antibody are combined. L'invention concerne un nouveau moyen de traitement du cancer dans lequel un inhibiteur de BTK réversible et un inhibiteur de point de contrôle de l'immunité sont combinés. Par exemple, l'invention concerne une composition pharmaceutique pour le traitement du cancer, dans laquelle un inhibiteur de BTK (I-A) et un anticorps anti-PD-1 sont combinés. 新しいがん治療手段として、可逆的BTK阻害剤と免疫チェックポイント阻害剤とを組み合わせた治療手段、例えば、下記BTK阻害剤(I-A): および抗PD-1抗体との組み合わせによる、がん治療のための医薬組成物が提供される。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; jpn
recordid cdi_epo_espacenet_WO2022102715A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMBINATION PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T18%3A33%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KASHIMOTO,%20Shigeki&rft.date=2022-05-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022102715A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true